Dr. Lauren Stevenson
Chief Scientific Officer & Head, Translational Sciences
As co-founder and head of the Translational Sciences Division, Lauren is leveraging her experience from both small and large biotech/pharma sectors to build a world class team of scientists who will partner directly with clients to provide translational strategies, facilitate regulatory engagements and deliver the assays, datasets and integrated analyses to advance drug development programs.
Lauren is a recognized industry-wide thought leader in biomarker development and large molecule bioanalysis and immunogenicity. She brings 20+ years of drug development experience, building and leading scientific teams with expertise in setting bioanalytical and biomarker strategies and developing PK, immunogenicity and biomarker assays in support of therapeutic programs that span multiple modalities and disease indications through all stages of development, from discovery to post-market. Using integrated scientific approaches, Lauren’s teams have a strong track record of reliably delivering high caliber science coupled with increased efficiencies that enable them to ‘do more with less’ and influence industry best practices and regulatory guidance. Externally, Lauren has authored multiple white papers and engages the broader industry and regulatory agencies as an invited speaker and course instructor at multiple conferences and workshops each year. In concert with her scientific role, Lauren is passionate about people development, has received certification as a Strengths coach and is active in mentorship and career development programs.
Dr. Lauren Stevenson
Chief Scientific Officer & Head, Translational Sciences
As co-founder and head of the Translational Sciences Division, Lauren is leveraging her experience from both small and large biotech/pharma sectors to build a world class team of scientists who will partner directly with clients to provide translational strategies, facilitate regulatory engagements and deliver the assays, datasets and integrated analyses to advance drug development programs.
Lauren is a recognized industry-wide thought leader in biomarker development and large molecule bioanalysis and immunogenicity. She brings 20+ years of drug development experience, building and leading scientific teams with expertise in setting bioanalytical and biomarker strategies and developing PK, immunogenicity and biomarker assays in support of therapeutic programs that span multiple modalities and disease indications through all stages of development, from discovery to post-market. Using integrated scientific approaches, Lauren’s teams have a strong track record of reliably delivering high caliber science coupled with increased efficiencies that enable them to ‘do more with less’ and influence industry best practices and regulatory guidance. Externally, Lauren has authored multiple white papers and engages the broader industry and regulatory agencies as an invited speaker and course instructor at multiple conferences and workshops each year. In concert with her scientific role, Lauren is passionate about people development, has received certification as a Strengths coach and is active in mentorship and career development programs.